|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/10 | (2006.01) |
| C12N 15/1055 | (2013.01) | ||
| C12N 15/65 | (2006.01) | ||
| C12N 15/65 | (2013.01) | ||
| C12N 15/67 | (2006.01) | ||
| C12N 15/67 | (2013.01) | ||
| C12Y 603/01002 | (2013.01) |
| (11) | Patento numeris | 3455359 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17727027.9 |
| Europos patento paraiškos padavimo data | 2017-05-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-03-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/032139 |
| Data | 2017-05-11 |
| (87) | Numeris | WO 2017/197098 |
| Data | 2017-11-16 |
| (30) | Numeris | Data | Šalis |
| 201662334966 P | 2016-05-11 | US |
| (72) |
KETCHEM, Randal R. , US
MCGREW, Jeffrey T. , US
FOMINA YADLIN, Dina A. , US
MUNRO, Trent P. , US
AGRAWAL, Neeraj Jagdish , US
DARIS, Kristine M. , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, CA 91320,
US
|
| (54) | DIRECT SELECTION OF CELLS EXPRESSING HIGH LEVELS OF HETEROMERIC PROTEINS USING GLUTAMINE SYNTHETASE INTRAGENIC COMPLEMENTATION VECTORS |
| DIRECT SELECTION OF CELLS EXPRESSING HIGH LEVELS OF HETEROMERIC PROTEINS USING GLUTAMINE SYNTHETASE INTRAGENIC COMPLEMENTATION VECTORS |